Literature DB >> 8795470

The St Vincent Task Force for diabetes: report of the cardiovascular disease subgroup.

B Pentecost1, J S Yudkin.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8795470      PMCID: PMC484455          DOI: 10.1136/hrt.76.2.107

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  16 in total

1.  NHLI BARI clinical alert on diabetics treated with angioplasty.

Authors:  J J Ferguson
Journal:  Circulation       Date:  1995-12-15       Impact factor: 29.690

2.  Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study.

Authors:  A Rosengren; L Welin; A Tsipogianni; L Wilhelmsen
Journal:  BMJ       Date:  1989-11-04

3.  Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies.

Authors:  K Malmberg; J Herlitz; A Hjalmarson; L Rydén
Journal:  Eur Heart J       Date:  1989-05       Impact factor: 29.983

4.  Clinical and coronary arteriographic features and outcome of recent onset unstable angina.

Authors:  A Kanojia; R Kasliwal; A Seth; S Bhandari; T S Kler; M L Bhatia
Journal:  Int J Cardiol       Date:  1993-06       Impact factor: 4.164

5.  Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.

Authors:  B J Rensing; W R Hermans; J Vos; J G Tijssen; W Rutch; N Danchin; G R Heyndrickx; E G Mast; W Wijns; P W Serruys
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

6.  Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus.

Authors:  J P Carrozza; R E Kuntz; R F Fishman; D S Baim
Journal:  Ann Intern Med       Date:  1993-03-01       Impact factor: 25.391

7.  Profile of coronary arterial disease in diabetic patients undergoing coronary arterial bypass grafting.

Authors:  A Bhan; B Das; H S Wasir; U Kaul; P Venugopal
Journal:  Int J Cardiol       Date:  1991-05       Impact factor: 4.164

8.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

9.  How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.

Authors:  J S Yudkin
Journal:  BMJ       Date:  1993-05-15

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  1 in total

1.  Pravastatin-induced changes in expression of long non-coding and coding RNAs in endothelial cells.

Authors:  Shweta Singh; Hien C Nguyen; Mehroz Ehsan; David C R Michels; Priyanka Singh; Mohammad Qadura; Krishna K Singh
Journal:  Physiol Rep       Date:  2021-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.